Celine Halioua, the founder of Loyal, a biotechnology company developing a potential longevity drug for dogs, represents a growing trend in the pet-longevity market, where the intersection of human desires for longer pet lives and advancements in canine health sciences have led to significant investments, promising treatments, and an exploration of the implications for human aging research. #DogLongevity #PetCare #Biotechnology #US #TX #CA #UK
Scientists at Bristol Myers Squibb's Devens facility are utilizing artificial intelligence to monitor critical variables in the production of disease-fighting proteins, enhancing drug manufacturing efficiency by 40% and tackling shortages, while the company faces tough competition from China's rapidly advancing biotech sector and implements cost-cutting measures in light of patent expirations and the potential impact of AI on jobs in the industry. #ArtificialIntelligence #PharmaceuticalInnovation #Biotechnology #US #CN #TH
Die Schließung mehrerer Produktionsstandorte von Biontech, die auf Überkapazitäten und Kosteneinsparungen zurückzuführen ist, wurde als schmerzhafter Einschnitt für die Biotechnologiebranche und die betroffenen Regionen bezeichnet, während die Gründer von Curevac dem Management von Biontech Täuschung vorwerfen und vermuten, dass die Schließungen mit Patentstreitigkeiten zusammenhängen könnten. #Biotechnology #Biopharma #JobLosses
At the Bristol Myers Squibb facility in Devens, Massachusetts, scientists are leveraging artificial intelligence to enhance the production of genetically engineered proteins for disease treatment, improving drug output by 40% and allowing real-time intervention during the manufacturing process, while facing challenges in translating technological advancements into broader productivity gains compared to China's rapidly scaling biotech sector. #ArtificialIntelligence #Biotechnology #DrugDiscovery #US #CN #TH
BOEBERT: "Implanting parts of aborted babies into laboratory animals? Have you heard of this kind of research?" (Original: BOEBERT : « Implanter des parties de bébés avortés dans des animaux de laboratoire ? Avez-vous entendu parler de ce genre de recherche ? » GOODMAN : « Nous avons réalisé une analyse montrant que plus de 90 % des expériences utilisant du tissu fœtal humain et les implantant dans) #AbortionResearch #EthicalDebate #Biotechnology #US #FR
Mark Zuckerberg and Priscilla Chan's Biohub is investing $500 million in a five-year initiative to create AI models of human cells, aiming to revolutionize disease research and treatment through open-access data while facing challenges in data scale and accuracy. #ArtificialIntelligence #Biotechnology #HealthInnovations #US #FR #DE #CN #JP #GB #IN
By the way, we have nice human pan-hanta mAbs that could be used as treatment. Last year we applied for EU funding to develop them clinically. The proposal was rejected. #Healthcare #Biotechnology #ResearchFunding
The U.S. Academy of Sciences has retracted Mariano Barbacid's cancer research study due to undisclosed conflicts of interest, as he and co-authors Vasiliki Liaki and Carmen Guerra failed to report their ownership in the biotech company Vega Oncotargets, which aims to fund new therapies. #CancerResearch #ConflictOfInterest #Biotechnology #US #GR #ES
American biotechnology company Regeneron has developed a groundbreaking gene therapy called Otarmeni to treat a rare genetic form of deafness, which has shown significant auditory improvement in at least 80% of 20 pediatric patients tested, and is set to be offered for free to eligible patients, marking a pivotal advance in treating genetic hearing loss. #GeneTherapy #HearingLoss #Biotechnology
